| Guidance on choosing qualitative evidence synthesis methods for use in health technology assessments of complex interventions A Booth, J Noyes, K Flemming, A Gerhardus, P Wahlster, GJ Van Der Wilt, ... Bremen (DE): Integrate-HTA, 1-38, 2016 | 251 | 2016 |
| Structured methodology review identified seven (RETREAT) criteria for selecting qualitative evidence synthesis approaches A Booth, J Noyes, K Flemming, A Gerhardus, P Wahlster, GJ van der Wilt, ... Journal of clinical epidemiology 99, 41-52, 2018 | 196 | 2018 |
| Health technology assessment (HTA): ethical aspects D Sacchini, A Virdis, P Refolo, M Pennacchini, I Carrasco de Paula Medicine, Health Care and Philosophy 12, 453-457, 2009 | 67 | 2009 |
| Patient-reported outcomes (PROs): the significance of using humanistic measures in clinical trial and clinical practice P Refolo, R Minacori, V Mele, D Sacchini, AG Spagnolo Eur Rev Med Pharmacol Sci 16 (10), 1319-1323, 2012 | 44 | 2012 |
| Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use A Cicchetti, A Berrino, M Casini, P Codella, G Facco, A Fiore, G Marano, ... Blood transfusion 14 (4), 287, 2016 | 41 | 2016 |
| Integrating ethics in health technology assessment: many ways to Rome B Hofmann, W Oortwijn, KB Lysdahl, P Refolo, D Sacchini, GJ van der Wilt, ... International journal of technology assessment in health care 31 (3), 131-137, 2015 | 40 | 2015 |
| Lay and professional stakeholder involvement in scoping palliative care issues: methods used in seven European countries L Brereton, C Ingleton, C Gardiner, E Goyder, K Mozygemba, KB Lysdahl, ... Palliative medicine 31 (2), 181-192, 2017 | 38 | 2017 |
| Ethical analysis in HTA of complex health interventions KB Lysdahl, W Oortwijn, GJ Van Der Wilt, P Refolo, D Sacchini, ... BMC Medical Ethics 17, 1-15, 2016 | 33 | 2016 |
| Why is it so difficult to integrate ethics in Health Technology Assessment (HTA)? The epistemological viewpoint P Refolo, D Sacchini, L Brereton, A Gerhardus, B Hofmann, KB Lysdahl, ... | 30 | 2016 |
| Testing the HTA Core Model: Experiences from two pilot projects I Pasternack, H Anttila, M Mäkelä, T Ikonen, P Räsänen, K Lampe, ... International journal of technology assessment in health care 25 (S2), 21-27, 2009 | 30 | 2009 |
| Integrating empirical analysis and normative inquiry in health technology assessment: the values in doing assessments of health technologies approach GJ Van Der Wilt, B Bloemen, J Grin, I Gutierrez-Ibarluzea, ... International Journal of Technology Assessment in Health Care 38 (1), e52, 2022 | 26 | 2022 |
| Sobre la «responsabilidad» de la vacunación ML Di Pietro, P Refolo, FJ González-Melado Cuadernos de bioetica 23 (2), 323-336, 2012 | 25 | 2012 |
| Taking patient heterogeneity and preferences into account in health technology assessments W Kievit, M Tummers, R Van Hoorn, A Booth, K Mozygemba, P Refolo, ... International Journal of Technology Assessment in Health Care 33 (5), 562-569, 2017 | 24 | 2017 |
| The development of PubMed search strategies for patient preferences for treatment outcomes R Van Hoorn, W Kievit, A Booth, K Mozygemba, KB Lysdahl, P Refolo, ... BMC medical research methodology 16, 1-7, 2016 | 24 | 2016 |
| Integrated assessment of home based palliative care with and without reinforced caregiver support:‘a demonstration of INTEGRATE-HTA methodological guidances’–executive summary L Brereton, P Wahlster, KB Lysdahl, K Mozygemba, J Burns, JB Chilcott, ... | 22 | 2016 |
| Ethical and deontological issues in Transfusion Medicine D Sacchini, GM Liumbruno, G Bruno, C Liumbruno, D Rafanelli, ... Blood Transfusion 11 (1), 14, 2013 | 22 | 2013 |
| L’Health Technology Assessment (HTA) ei suoi aspetti etici D Sacchini, P Refolo Medicina e Morale 56 (1), 2007 | 21 | 2007 |
| Stakeholder involvement throughout health technology assessment: an example from palliative care L Brereton, P Wahlster, K Mozygemba, KB Lysdahl, J Burns, S Polus, ... International journal of technology assessment in health care 33 (5), 552-561, 2017 | 20 | 2017 |
| Prioritization of high-cost new drugs for HCV: making sustainability ethical L Craxi, D Sacchini, P Refolo, R Minacori, V D'Aloiso, G Ricci, R Bruno, ... European review for medical and pharmacological sciences, 1044-1051, 2016 | 19 | 2016 |
| Ethical aspects of fecal microbiota transplantation (FMT) V Daloiso, R Minacori, P Refolo, D Sacchini, L Craxi, A Gasbarrini, ... Eur Rev Med Pharmacol Sci 19 (17), 3173-80, 2015 | 19 | 2015 |
